Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ABSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 1.792M
March 31, 2026 2.558M
December 31, 2025 3.497M
September 30, 2025 4.466M
June 30, 2025 5.707M
March 31, 2025 7.261M
December 31, 2024 8.497M
September 30, 2024 10.42M
June 30, 2024 11.73M
March 31, 2024 12.66M
December 31, 2023 14.28M
September 30, 2023 16.00M
June 30, 2023 17.73M
Date Value
March 31, 2023 19.53M
December 31, 2022 21.29M
September 30, 2022 20.50M
June 30, 2022 21.90M
March 31, 2022 16.67M
December 31, 2021 18.51M
September 30, 2021 20.25M
June 30, 2021 169.20M
March 31, 2021 143.85M
December 31, 2020 13.10M
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. 84.96M
Prime Medicine, Inc. 103.51M
Beam Therapeutics, Inc. 232.15M
Tenax Therapeutics, Inc. 0.00
Manhattan Scientifics, Inc. --